Umbilical Cord Blood Unit With C3A Fragment
Myelodysplastic Syndromes
Masonic Cancer Center, University of MinnesotaCell therapyPhase 1/2Dormant
CC
41/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 65/ 100
Competitive context
138 Active assets in the Myelodysplastic Syndromes cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cyclophosphamide Sawa Ito, MD | Phase 4 | BB |
FILGRASTIM City of Hope Medical Center | Phase 4 | BB |
Daunorubicin OHSU Knight Cancer Institute | Phase 3 | BB |
Cytosin-Arabinosid The First Affiliated Hospital of Soochow University | Phase 4 | BB |
ETOPOSIDE Memorial Sloan Kettering Cancer Center | Phase 3 | BB |
View all 50 →
Same molecule, other indications
Umbilical Cord Blood Unit With C3A Fragment is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →